Personalised uroflowmetry solution for the analysis of LUTS

  • Tel Aviv
  • David Akunis, CEO, david@flometrica.co.il

Flometrica is committed to providing personalised digital health solutions for the diagnosis, monitoring and treatment of patients with urological or renal disorders, which affects almost 10% of the population. Our products enable early detection of serious clinical conditions, allow patients to perform the tests at home and at any time; provide better and predictive therapy to both patients and physicians, resolve inefficiencies that currently exist in the health care system, reduce costs associated with patients and hospitals and introduce important monitoring that is not presently practical.




Digital Health


$500K ($200K commitment in place)